Liver Cancer News & Features
The risk of disease recurrence in liver cancer patients who have undergone a liver transplant can now be more accurately calculated, thanks to new tool.
An interventional x-ray guidance device approved by the U.S. Food and Drug Administration in 2013 may have the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy for liver cancer.
AlluraClarity, an FDA-approved X-ray guidance device, has the potential to reduce radiation exposure in patients with liver cancer.
Triclosan, a popular antimicrobial agent in soaps, detergents, and plastics, has been found to promote liver cancer in mice.
Liver tumor cells do not respond to sorafenib if they have a less differentiated phenotype, known as the mesenchymal type, and express CD44, according to a new study.
Liver Cancer Videos
Liver Cancer Clinical Trials
- E-cigarettes declared a health threat by California health officials
- Study makes a case for wider gene testing in patients with colorectal cancer
- New study helps physicians and patients determine prostate cancer risk
- Effectiveness of nanoparticle drugs was hindered by tumor microenvironment in triple-negative breast cancer
- Existing drug extends survival for patients with rare thymic carcinoma
- Oncology patient navigation: Bringing this crucial role to the forefront
- Radiation plus hormone therapy prolongs survival for older men with prostate cancer
- Mistletoe: The holiday plant is making headlines as an alternative cancer treatment
- Using genomic correlates of radiotoxicity to predict patient outcomes
- Therapy dogs may encourage cancer patient to persevere with treatment
- Research promising for reducing risk of breast cancer spreading to the brain
- Biopsies with DCIS diagnosis increase for women undergoing mammography
- Fear of cancer may have unwanted effect on public screening uptake
- PDE-5 inhibitors increase risk of biochemical recurrence after radical prostatectomy
- Many breast cancer patients lack basic knowledge about their disease
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|